BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26781229)

  • 1. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
    White J; Sofat R; Hemani G; Shah T; Engmann J; Dale C; Shah S; Kruger FA; Giambartolomei C; Swerdlow DI; Palmer T; McLachlan S; Langenberg C; Zabaneh D; Lovering R; Cavadino A; Jefferis B; Finan C; Wong A; Amuzu A; Ong K; Gaunt TR; Warren H; Davies TL; Drenos F; Cooper J; Ebrahim S; Lawlor DA; Talmud PJ; Humphries SE; Power C; Hypponen E; Richards M; Hardy R; Kuh D; Wareham N; Ben-Shlomo Y; Day IN; Whincup P; Morris R; Strachan MW; Price J; Kumari M; Kivimaki M; Plagnol V; Whittaker JC; ; Smith GD; Dudbridge F; Casas JP; Holmes MV; Hingorani AD;
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):327-36. PubMed ID: 26781229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis.
    Saleheen D; Haycock PC; Zhao W; Rasheed A; Taleb A; Imran A; Abbas S; Majeed F; Akhtar S; Qamar N; Zaman KS; Yaqoob Z; Saghir T; Rizvi SNH; Memon A; Mallick NH; Ishaq M; Rasheed SZ; Memon FU; Mahmood K; Ahmed N; Frossard P; Tsimikas S; Witztum JL; Marcovina S; Sandhu M; Rader DJ; Danesh J
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):524-533. PubMed ID: 28408323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
    Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
    Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    Keenan T; Zhao W; Rasheed A; Ho WK; Malik R; Felix JF; Young R; Shah N; Samuel M; Sheikh N; Mucksavage ML; Shah O; Li J; Morley M; Laser A; Mallick NH; Zaman KS; Ishaq M; Rasheed SZ; Memon FU; Ahmed F; Hanif B; Lakhani MS; Fahim M; Ishaq M; Shardha NK; Ahmed N; Mahmood K; Iqbal W; Akhtar S; Raheel R; O'Donnell CJ; Hengstenberg C; März W; Kathiresan S; Samani N; Goel A; Hopewell JC; Chambers J; Cheng YC; Sharma P; Yang Q; Rosand J; Boncoraglio GB; Kazmi SU; Hakonarson H; Köttgen A; Kalogeropoulos A; Frossard P; Kamal A; Dichgans M; Cappola T; Reilly MP; Danesh J; Rader DJ; Voight BF; Saleheen D
    J Am Coll Cardiol; 2016 Feb; 67(4):407-416. PubMed ID: 26821629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study.
    Li X; Meng X; He Y; Spiliopoulou A; Timofeeva M; Wei WQ; Gifford A; Yang T; Varley T; Tzoulaki I; Joshi P; Denny JC; Mckeigue P; Campbell H; Theodoratou E
    PLoS Med; 2019 Oct; 16(10):e1002937. PubMed ID: 31626644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives.
    Richardson TG; Wang Q; Sanderson E; Mahajan A; McCarthy MI; Frayling TM; Ala-Korpela M; Sniderman A; Smith GD; Holmes MV
    Lancet Healthy Longev; 2021 Jun; 2(6):e317-e326. PubMed ID: 34729547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
    ; Swerdlow DI; Holmes MV; Kuchenbaecker KB; Engmann JE; Shah T; Sofat R; Guo Y; Chung C; Peasey A; Pfister R; Mooijaart SP; Ireland HA; Leusink M; Langenberg C; Li KW; Palmen J; Howard P; Cooper JA; Drenos F; Hardy J; Nalls MA; Li YR; Lowe G; Stewart M; Bielinski SJ; Peto J; Timpson NJ; Gallacher J; Dunlop M; Houlston R; Tomlinson I; Tzoulaki I; Luan J; Boer JM; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Ferrucci L; Bandenelli S; Tanaka T; Meschia JF; Singleton A; Navis G; Mateo Leach I; Bakker SJ; Gansevoort RT; Ford I; Epstein SE; Burnett MS; Devaney JM; Jukema JW; Westendorp RG; Jan de Borst G; van der Graaf Y; de Jong PA; Mailand-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Stephens JW; Eaton CB; Robinson JG; Manson JE; Fowkes FG; Frayling TM; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Redline S; Lange LA; Kumari M; Wareham NJ; Verschuren WM; Benjamin EJ; Whittaker JC; Hamsten A; Dudbridge F; Delaney JA; Wong A; Kuh D; Hardy R; Castillo BA; Connolly JJ; van der Harst P; Brunner EJ; Marmot MG; Wassel CL; Humphries SE; Talmud PJ; Kivimaki M; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Hakonarson H; Reiner AP; Keating BJ; Sattar N; Hingorani AD; Casas JP
    Lancet; 2012 Mar; 379(9822):1214-24. PubMed ID: 22421340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urate, Blood Pressure, and Cardiovascular Disease: Evidence From Mendelian Randomization and Meta-Analysis of Clinical Trials.
    Gill D; Cameron AC; Burgess S; Li X; Doherty DJ; Karhunen V; Abdul-Rahim AH; Taylor-Rowan M; Zuber V; Tsao PS; Klarin D; ; Evangelou E; Elliott P; Damrauer SM; Quinn TJ; Dehghan A; Theodoratou E; Dawson J; Tzoulaki I
    Hypertension; 2021 Feb; 77(2):383-392. PubMed ID: 33356394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
    Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration
    Lancet Diabetes Endocrinol; 2021 Dec; 9(12):837-846. PubMed ID: 34717822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study.
    Yang Y; Xian W; Wu D; Huo Z; Hong S; Li Y; Xiao H
    Front Endocrinol (Lausanne); 2022; 13():917056. PubMed ID: 35992130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials.
    Efstathiadou A; Gill D; McGrane F; Quinn T; Dawson J
    J Am Heart Assoc; 2019 Sep; 8(17):e012738. PubMed ID: 31438759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
    Voight BF; Peloso GM; Orho-Melander M; Frikke-Schmidt R; Barbalic M; Jensen MK; Hindy G; Hólm H; Ding EL; Johnson T; Schunkert H; Samani NJ; Clarke R; Hopewell JC; Thompson JF; Li M; Thorleifsson G; Newton-Cheh C; Musunuru K; Pirruccello JP; Saleheen D; Chen L; Stewart A; Schillert A; Thorsteinsdottir U; Thorgeirsson G; Anand S; Engert JC; Morgan T; Spertus J; Stoll M; Berger K; Martinelli N; Girelli D; McKeown PP; Patterson CC; Epstein SE; Devaney J; Burnett MS; Mooser V; Ripatti S; Surakka I; Nieminen MS; Sinisalo J; Lokki ML; Perola M; Havulinna A; de Faire U; Gigante B; Ingelsson E; Zeller T; Wild P; de Bakker PI; Klungel OH; Maitland-van der Zee AH; Peters BJ; de Boer A; Grobbee DE; Kamphuisen PW; Deneer VH; Elbers CC; Onland-Moret NC; Hofker MH; Wijmenga C; Verschuren WM; Boer JM; van der Schouw YT; Rasheed A; Frossard P; Demissie S; Willer C; Do R; Ordovas JM; Abecasis GR; Boehnke M; Mohlke KL; Daly MJ; Guiducci C; Burtt NP; Surti A; Gonzalez E; Purcell S; Gabriel S; Marrugat J; Peden J; Erdmann J; Diemert P; Willenborg C; König IR; Fischer M; Hengstenberg C; Ziegler A; Buysschaert I; Lambrechts D; Van de Werf F; Fox KA; El Mokhtari NE; Rubin D; Schrezenmeir J; Schreiber S; Schäfer A; Danesh J; Blankenberg S; Roberts R; McPherson R; Watkins H; Hall AS; Overvad K; Rimm E; Boerwinkle E; Tybjaerg-Hansen A; Cupples LA; Reilly MP; Melander O; Mannucci PM; Ardissino D; Siscovick D; Elosua R; Stefansson K; O'Donnell CJ; Salomaa V; Rader DJ; Peltonen L; Schwartz SM; Altshuler D; Kathiresan S
    Lancet; 2012 Aug; 380(9841):572-80. PubMed ID: 22607825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels.
    Rasheed H; Hughes K; Flynn TJ; Merriman TR
    Circ Cardiovasc Genet; 2014 Dec; 7(6):830-7. PubMed ID: 25249548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
    Li X; Meng X; Timofeeva M; Tzoulaki I; Tsilidis KK; Ioannidis JP; Campbell H; Theodoratou E
    BMJ; 2017 Jun; 357():j2376. PubMed ID: 28592419
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.
    Ye Z; Sharp SJ; Burgess S; Scott RA; Imamura F; ; Langenberg C; Wareham NJ; Forouhi NG
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):35-42. PubMed ID: 25281353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating a possible causal relationship between maternal serum urate concentrations and offspring birthweight: a Mendelian randomization study.
    Decina CS; Hopkins R; Bowden J; Shields BM; Lawlor DA; Warrington NM; Evans DM; Freathy RM; Beaumont RN
    Int J Epidemiol; 2023 Feb; 52(1):178-189. PubMed ID: 36191079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.
    Yang F; Lu Y; Chen S; Wang K; Hu T; Cui H
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1266-1274. PubMed ID: 35197211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.